Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: May 8, 2024
Reporting Period: This filing reports on events occurring on May 8, 2024, specifically regarding upcoming investor presentations.
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing serves solely to disclose the use of an investor presentation for upcoming meetings.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing indicates that executive officers intend to use the material in Exhibit 99.1 (Investor Presentation dated May 2024) for upcoming presentations to investors and analysts.
Guidance, Outlook, and Risks
Management Commentary: The filing notes that the information provided, including the attached investor presentation, is furnished pursuant to Item 7.01 of Regulation FD and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Risks and Contingencies: No specific risks or contingencies are detailed in this text. The filing explicitly states that the information is not incorporated by reference into other filings unless expressly set forth by specific reference.
Investor Verification Checklist
- Verify the contents of Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated May 2024) for actual financial data and strategic outlook, as this 8-K only references the document.
- Confirm the schedule of upcoming investor presentations mentioned by executive officers.
- Note that the information in this filing is not legally "filed" under Section 18 of the Exchange Act and carries different liability standards than a formal 10-K or 10-Q.